propofol has been researched along with quinoxalines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, SM; Xu, AJ; Zeng, YM | 1 |
| Andresen, MC; Bailey, TW; McDougall, SJ; Mendelowitz, D | 1 |
2 other study(ies) available for propofol and quinoxalines
| Article | Year |
|---|---|
Effects of intrathecal NMDA and AMPA receptors agonists or antagonists on antinociception of propofol.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics; Animals; Dizocilpine Maleate; Female; Injections, Spinal; Male; Mice; N-Methylaspartate; Nociceptors; Pain Threshold; Propofol; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2004 |
Propofol enhances both tonic and phasic inhibitory currents in second-order neurons of the solitary tract nucleus (NTS).
Topics: 2-Amino-5-phosphonovalerate; Anesthetics, Intravenous; Animals; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Neural Inhibition; Neurons; Patch-Clamp Techniques; Propofol; Quinoxalines; Rats; Rats, Sprague-Dawley; Solitary Nucleus; Tetrodotoxin | 2008 |